BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17722516)

  • 21. Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.
    Liu J; Liu J; Chu L; Wang Y; Duan Y; Feng L; Yang C; Wang L; Kong D
    Int J Nanomedicine; 2010 Dec; 6():59-69. PubMed ID: 21289982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and characterization of photocurable polyamidoamine dendrimer hydrogels as a versatile platform for tissue engineering and drug delivery.
    Desai PN; Yuan Q; Yang H
    Biomacromolecules; 2010 Mar; 11(3):666-73. PubMed ID: 20108892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conjugation of iron oxide nanoparticles with RGD-modified dendrimers for targeted tumor MR imaging.
    Yang J; Luo Y; Xu Y; Li J; Zhang Z; Wang H; Shen M; Shi X; Zhang G
    ACS Appl Mater Interfaces; 2015 Mar; 7(9):5420-8. PubMed ID: 25695661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different patterns of nuclear and mitochondrial penetration by the G3 PAMAM dendrimer and its biotin-pyridoxal bioconjugate BC-PAMAM in normal and cancer cells in vitro.
    Uram Ł; Szuster M; Filipowicz A; Gargasz K; Wołowiec S; Wałajtys-Rode E
    Int J Nanomedicine; 2015; 10():5647-61. PubMed ID: 26379435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An innovative in situ method of creating hybrid dendrimer nano-assembly: An efficient next generation dendritic platform for drug delivery.
    Singh MK; Kuncha M; Nayak VL; Sarma AVS; Kumar MJM; Chauhan AS; Sistla R
    Nanomedicine; 2019 Oct; 21():102043. PubMed ID: 31247312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative toxicological assessment of PAMAM and thiophosphoryl dendrimers using embryonic zebrafish.
    Pryor JB; Harper BJ; Harper SL
    Int J Nanomedicine; 2014; 9():1947-56. PubMed ID: 24790436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendrimers: A versatile nanocarrier for drug delivery and targeting.
    Sherje AP; Jadhav M; Dravyakar BR; Kadam D
    Int J Pharm; 2018 Sep; 548(1):707-720. PubMed ID: 30012508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arginine-glycine-aspartic acid-polyethylene glycol-polyamidoamine dendrimer conjugate improves liver-cell aggregation and function in 3-D spheroid culture.
    Chen Z; Lian F; Wang X; Chen Y; Tang N
    Int J Nanomedicine; 2016; 11():4247-59. PubMed ID: 27621619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
    Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
    J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation.
    Casanellas I; Lagunas A; Tsintzou I; Vida Y; Collado D; Pérez-Inestrosa E; Rodríguez-Pereira C; Magalhaes J; Gorostiza P; Andrades JA; Becerra J; Samitier J
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dendritic systems for drug delivery applications].
    Iwamura M
    Nihon Rinsho; 2006 Feb; 64(2):231-7. PubMed ID: 16454175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. gamma-Glutamyl PAMAM dendrimer as versatile precursor for dendrimer-based targeting devices.
    Uehara T; Ishii D; Uemura T; Suzuki H; Kanei T; Takagi K; Takama M; Murakami M; Akizawa H; Arano Y
    Bioconjug Chem; 2010 Jan; 21(1):175-81. PubMed ID: 20000792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload.
    Kolhe P; Khandare J; Pillai O; Kannan S; Lieh-Lai M; Kannan RM
    Biomaterials; 2006 Feb; 27(4):660-9. PubMed ID: 16054211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted nanosystems: Advances in targeted dendrimers for cancer therapy.
    Yang H
    Nanomedicine; 2016 Feb; 12(2):309-16. PubMed ID: 26706410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro enzymatic stability of dendritic peptides.
    Yang H; Lopina ST
    J Biomed Mater Res A; 2006 Feb; 76(2):398-407. PubMed ID: 16270346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications of dendrimers in tissue engineering.
    Joshi N; Grinstaff M
    Curr Top Med Chem; 2008; 8(14):1225-36. PubMed ID: 18855707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
    Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
    Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Star poly(ε-caprolactone)-based electrospun fibers as biocompatible scaffold for doxorubicin with prolonged drug release activity.
    Bala Balakrishnan P; Gardella L; Forouharshad M; Pellegrino T; Monticelli O
    Colloids Surf B Biointerfaces; 2018 Jan; 161():488-496. PubMed ID: 29128835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cell viability and T2 relaxivity of fluorescein conjugated SPION-PAMAM third generation nanodendrimers for bioimaging.
    Khosroshahi ME; Rezvani HA; Keshvari H; Bonakdar S; Tajabadi M
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():544-52. PubMed ID: 26952457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
    Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
    Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.